deoxyglucose has been researched along with Carcinoma, Non-Small Cell Lung in 39 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (51.28) | 18.2507 |
| 2000's | 3 (7.69) | 29.6817 |
| 2010's | 14 (35.90) | 24.3611 |
| 2020's | 2 (5.13) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Han, R; Hao, S; He, Y; Li, L; Lin, C; Lu, C; Wang, Y | 1 |
| Kagimoto, A; Mimae, T; Miyata, Y; Okada, M; Tsutani, Y | 1 |
| Abe, H; Ahn, JM; Chen, M; Choe, JH; Choi, H; Endo, H; Goodwin, J; Helke, KL; Inoue, M; Jenkins, DMR; Jeong, JY; Kim, JW; Lee, SY; Minna, JD; Neugent, ML; Robinson, MW; Ruthenborg, RJ; Shackelford, DB; Singh, PK; Takeda, N; Wake, M; Xuan, Z; Yoo, H | 1 |
| He, Y; Khuri, FR; Liu, F; Liu, X; Liu, Y; Mao, K; Marcus, AI; Sun, SY; Zhong, D; Zhou, W | 1 |
| Cho, BC; Hong, YK; Kim, HJ; Kim, JH; Kim, SM; Solca, F; Yun, MR | 1 |
| Ahmad, M; Chatterjee, S; Hahn, IF | 1 |
| Bremner, RM; Fowler, AJ; Friel, JM; Inge, LJ; Richer, AL; Smith, MA; Tran, NL; Whitsett, T | 1 |
| Chen, YQ; Gao, J; Geng, GJ; Jiang, J; Li, CL; Li, N; Liu, Y; Luo, XY; Mi, YJ; Yu, XY; Zou, ZZ | 1 |
| Jiang, S; Nie, P; Tang, J; Wen, R; Xiao, Y; Zou, Z | 1 |
| Hou, XB; Li, TH; Liu, Y; Ren, ZP | 1 |
| Fu, H; Liu, X; Sun, L; Zhong, D; Zhou, W | 1 |
| Bremner, RM; Coon, KD; Inge, LJ; Smith, MA | 1 |
| Han, A; Li, M; Liu, Y; Ma, L; Sun, Y; Yu, J; Zhao, S; Zheng, J | 1 |
| Ittarat, W; Sinthupibulyakit, C; St Clair, DK; St Clair, WH | 1 |
| Brock, SE; Mitchell, RA; Rendon, BE; Yaddanapudi, K | 1 |
| Bandugula, VR; N, RP | 1 |
| Krynetskaia, N; Krynetskiy, E; Phadke, M | 1 |
| Braunschweiger, P; De Young, LR; Hamilton, K; Lampidis, TJ; Maschek, G; Priebe, W; Savaraj, N; Tidmarsh, GF | 1 |
| Cao, G; Cheng, Q; Li, S; Liu, X; Luo, F; Wang, H; Xia, Q; Yan, N | 1 |
| Dewan, NA; Gobar, LS; Hauser, LG; Scott, WJ; Sugimoto, JT; Sunderland, JJ | 1 |
| Dussek, J; Gee, T; Griffin, S; Lewis, P; Malsey, M; Marsden, P; Nunan, T | 1 |
| Alpert, NM; Babich, JW; Choi, NC; Fischman, AJ; Hamberg, LM; Hunter, GJ | 1 |
| Greenough, RL; Meyer, CR; Orringer, MB; Quint, LE; Wahl, RL; White, RI | 1 |
| Choi, NC; Fischman, AJ; Hunter, GJ; McLoud, TC | 1 |
| Blahd, W; Brown, C; Khonsary, A; Mandelkern, M; Santiago, SM; Sazon, DA; Soo Hoo, GW; Williams, AJ | 1 |
| Akashi, Y; Fukumura, T; Ichiya, Y; Ishida, T; Kuwabara, Y; Masuda, K; Murayama, S; Sasaki, M; Sugio, K; Yoshida, T | 1 |
| Anscher, MS; Hebert, ME; Hoffman, JM; Lowe, VJ; Patz, EF | 1 |
| Alpert, NM; Choi, NC; Fischman, AJ; Hamberg, LM; Hunter, GJ | 1 |
| Miyauchi, T; Wahl, RL | 1 |
| Bury, T; Corhay, JL; D'Harcour, JB; Limet, R; Paulus, P; Radermecker, MF; Rigo, P; Weber, T | 1 |
| Gambhir, SS; Hoh, CK; Madar, I; Maddahi, J; Phelps, ME | 1 |
| Bury, T; Dowlati, A; Hustinx, R; Paulus, P; Radermecker, M; Rigo, P | 1 |
| Albert, A; Bury, T; Corhay, JL; Dowlati, A; Ghaye, B; Limet, R; Paulus, P; Radermecker, M; Rigo, P; Schoffers, J; Weber, T | 1 |
| Allemann, F; Berthold, T; Engel, H; Hauser, M; Steinert, HC; von Schulthess, GK; Weder, W | 1 |
| Guhlmann, A; Kotzerke, J; Moog, F; Reske, SN; Storck, M; Sunder-Plassmann, L | 1 |
| Schiepers, C | 1 |
| Makler, PT | 1 |
| Abe, Y; Fujiwara, T; Fukuda, H; Hatazawa, J; Ido, T; Itoh, M; Kubota, K; Matsuzawa, T; Tada, M; Yamaguchi, K | 1 |
1 trial(s) available for deoxyglucose and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Whole-body 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer.
Topics: Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Preoperative Care; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed | 1994 |
38 other study(ies) available for deoxyglucose and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Hexokinases II-mediated glycolysis governs susceptibility to crizotinib in ALK-positive non-small cell lung cancer.
Topics: Anaplastic Lymphoma Kinase; Antimetabolites; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Crizotinib; Deoxyglucose; Glycolysis; Hexokinase; Humans; Lung Neoplasms; Neoplasm Invasiveness; Protein Kinase Inhibitors | 2021 |
Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Humans; Lung Neoplasms; Neoplasm Staging; Pneumonectomy; Retrospective Studies; Small Cell Lung Carcinoma | 2022 |
The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cohort Studies; Deoxyglucose; Female; Fluorodeoxyglucose F18; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Hydroxybenzoates; Lung; Lung Neoplasms; Male; Mice; Mice, Nude; Middle Aged; Phenotype; Positron-Emission Tomography; Prognosis; Survival Analysis; Up-Regulation; Xenograft Model Antitumor Assays | 2017 |
Inhibition of IGF1R enhances 2-deoxyglucose in the treatment of non-small cell lung cancer.
Topics: AMP-Activated Protein Kinase Kinases; Animals; Apoptosis; Biomarkers; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Deoxyglucose; Disease Models, Animal; Drug Synergism; Humans; Lung Neoplasms; Mice; Phosphorylation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyrazoles; Receptor, IGF Type 1; Receptors, Somatomedin; Triazines; Xenograft Model Antitumor Assays | 2018 |
Glycolysis inhibition sensitizes non-small cell lung cancer with T790M mutation to irreversible EGFR inhibitors via translational suppression of Mcl-1 by AMPK activation.
Topics: Afatinib; AMP-Activated Protein Kinases; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Drug Resistance, Neoplasm; ErbB Receptors; Glycolysis; Humans; Mutation; Myeloid Cell Leukemia Sequence 1 Protein; Protein Biosynthesis; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; TOR Serine-Threonine Kinases | 2013 |
GRP78 up-regulation leads to hypersensitization to cisplatin in A549 lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Death; Cell Line, Tumor; Cisplatin; Deoxyglucose; Drug Hypersensitivity; Endoplasmic Reticulum Chaperone BiP; Flow Cytometry; Heat-Shock Proteins; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; NF-kappa B; Tunicamycin; Up-Regulation | 2014 |
LKB1 inactivation sensitizes non-small cell lung cancer to pharmacological aggravation of ER stress.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Animals; Antineoplastic Agents; Apoptosis; Brefeldin A; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxyglucose; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Heat-Shock Proteins; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Mice, Knockout; Mice, Transgenic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species; Tunicamycin; Unfolded Protein Response | 2014 |
Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells.
Topics: Adenosine Triphosphate; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Caspase 8; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Drug Synergism; Gene Expression Regulation, Neoplastic; Glucose; Glucose Transporter Type 1; Glycolysis; Humans; Lung Neoplasms; Signal Transduction; TOR Serine-Threonine Kinases | 2015 |
Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Topics: Adaptor Proteins, Signal Transducing; Apoptosis; Benzamides; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Down-Regulation; Gene Knockdown Techniques; Glycolysis; Humans; Lung Neoplasms; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Morpholines; Multiprotein Complexes; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Pyrimidines; Rapamycin-Insensitive Companion of mTOR Protein; Regulatory-Associated Protein of mTOR; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Stem Cell Assay | 2015 |
Combination of 2-deoxy d-glucose and metformin for synergistic inhibition of non-small cell lung cancer: A reactive oxygen species and P-p38 mediated mechanism.
Topics: A549 Cells; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Survival; Deoxyglucose; DNA Adducts; DNA Damage; Drug Synergism; Humans; Intracellular Space; L-Lactate Dehydrogenase; Lipid Peroxidation; Lung Neoplasms; Membrane Potential, Mitochondrial; Metformin; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species | 2016 |
2-Deoxyglucose Suppresses ERK Phosphorylation in LKB1 and Ras Wild-Type Non-Small Cell Lung Cancer Cells.
Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxyglucose; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Insulin-Like Growth Factor I; Lung Neoplasms; Mutation; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; ras Proteins; Signal Transduction | 2016 |
Expression of LKB1 tumor suppressor in non-small cell lung cancer determines sensitivity to 2-deoxyglucose.
Topics: AMP-Activated Protein Kinase Kinases; Antimetabolites; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Protein Serine-Threonine Kinases; Tumor Cells, Cultured | 2009 |
Relationship between primary lesion FDG uptake and clinical stage at PET-CT for non-small cell lung cancer patients: An observation.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Deoxyglucose; Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Radiography; Retrospective Studies; Spectrometry, X-Ray Emission | 2010 |
p53 Protects lung cancer cells against metabolic stress.
Topics: Adaptation, Physiological; Adenosine Triphosphate; Antioxidants; Apoptosis Regulatory Proteins; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cytoprotection; Deoxyglucose; Humans; Intracellular Signaling Peptides and Proteins; Lung Neoplasms; Mitochondrial Proteins; Molecular Chaperones; Oxidative Phosphorylation; Oxidative Stress; Phosphoric Monoester Hydrolases; Reactive Oxygen Species; Stress, Physiological; Time Factors; Tumor Suppressor Protein p53 | 2010 |
Negative regulation of AMP-activated protein kinase (AMPK) activity by macrophage migration inhibitory factor (MIF) family members in non-small cell lung carcinomas.
Topics: Acetylcysteine; AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Antigens, Differentiation, B-Lymphocyte; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Deoxyglucose; Enzyme Activation; Free Radical Scavengers; Glucose; Histocompatibility Antigens Class II; Humans; Immunoblotting; Intramolecular Oxidoreductases; Lung Neoplasms; Macrophage Migration-Inhibitory Factors; Mutation; Oxidation-Reduction; Phosphorylation; Protein Serine-Threonine Kinases; Reactive Oxygen Species; RNA Interference; Signal Transduction; TOR Serine-Threonine Kinases | 2012 |
2-Deoxy-D-glucose and ferulic acid modulates radiation response signaling in non-small cell lung cancer cells.
Topics: Antimetabolites; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Non-Small-Cell Lung; Caspase 3; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Coumaric Acids; Cyclin-Dependent Kinase Inhibitor p21; Deoxyglucose; DNA Repair; Free Radical Scavengers; Humans; Lung Neoplasms; NF-kappa B; Nuclear Proteins; Radiation-Sensitizing Agents; Signal Transduction; Tumor Suppressor Protein p53 | 2013 |
Cytotoxicity of chemotherapeutic agents in glyceraldehyde-3-phosphate dehydrogenase-depleted human lung carcinoma A549 cells with the accelerated senescence phenotype.
Topics: Adenosine Triphosphate; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Division; Cellular Senescence; Deoxyglucose; Drug Resistance, Neoplasm; Energy Metabolism; Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+); Glycolysis; Hexokinase; Humans; Lung Neoplasms; Neoplasm Proteins; Phenotype; RNA Interference; RNA, Small Interfering; S Phase | 2013 |
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo.
Topics: Animals; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Doxorubicin; Drug Synergism; Humans; Lung Neoplasms; Mice; Mice, Nude; Osteosarcoma; Paclitaxel; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
Topics: Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Culture Media; Deoxyglucose; Down-Regulation; Flow Cytometry; Genetic Vectors; Glucose Transporter Type 1; Glycolysis; HEPES; Hexokinase; Humans; Hydrogen-Ion Concentration; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; In Situ Nick-End Labeling; Lactates; Lung Neoplasms; Models, Statistical; Oxygen; Phosphoglycerate Kinase; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; RNA, Small Interfering; Time Factors; Transfection; Up-Regulation | 2006 |
Detection of scalene lymph node metastases from lung cancer. Positron emission tomography.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Middle Aged; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed | 1995 |
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Models, Biological; Time Factors; Tomography, Emission-Computed | 1994 |
Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1994 |
Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Middle Aged; Tomography, Emission-Computed | 1993 |
Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer.
Topics: Adenocarcinoma; Aged; Animals; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinal Neoplasms; Middle Aged; Radiography, Thoracic; Tomography, Emission-Computed | 1996 |
The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Evaluation Studies as Topic; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mediastinum; Predictive Value of Tests; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: preliminary findings.
Topics: Carcinoma in Situ; Carcinoma, Non-Small-Cell Lung; Cicatrix; Deoxyglucose; Fibrosis; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Lung; Lung Diseases; Lung Neoplasms; Neoplasm, Residual; Prospective Studies; Remission Induction; Survival Rate; Tomography, Emission-Computed; Tomography, X-Ray Computed; Treatment Outcome | 1996 |
Simplified measurement of deoxyglucose utilization rate.
Topics: Blood Glucose; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Lung Neoplasms; Tomography, Emission-Computed | 1996 |
Regional 2-[18F]fluoro-2-deoxy-D-glucose uptake varies in normal lung.
Topics: Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Case-Control Studies; Deoxyglucose; False Negative Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lung; Lung Neoplasms; Male; Middle Aged; Time Factors; Tomography, Emission-Computed | 1996 |
PET scanning said to save money and improve staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cost Savings; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hospital Costs; Humans; Lung Neoplasms; Mediastinal Neoplasms; Neoplasm Staging; Solitary Pulmonary Nodule; Tomography, Emission-Computed | 1995 |
[Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Magnetic Resonance Imaging; Male; Mediastinoscopy; Mediastinum; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Thoracotomy; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Cost-Benefit Analysis; Decision Trees; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Life Expectancy; Lung Neoplasms; Male; Neoplasm Staging; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Staging of non-small-cell lung cancer by whole-body fluorine-18 deoxyglucose positron emission tomography.
Topics: Aged; Bone and Bones; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; False Positive Reactions; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Neoplasm Staging; Prospective Studies; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Staging of the mediastinum: value of positron emission tomography imaging in non-small cell lung cancer.
Topics: Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymphatic Metastasis; Mediastinum; Neoplasm Staging; Predictive Value of Tests; Preoperative Care; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1996 |
Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Topics: Adult; Aged; Biopsy; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Lymph Nodes; Male; Middle Aged; Neoplasm Staging; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1997 |
Role of positron emission tomography in the staging of lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Deoxyglucose; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Neoplasm Staging; Radiopharmaceuticals; Tomography, Emission-Computed | 1997 |
Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma.
Topics: Carcinoma, Non-Small-Cell Lung; Cost Savings; Cost-Benefit Analysis; Decision Support Techniques; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Tomography, Emission-Computed | 1997 |
Clinical assessment of therapeutic effects on cancer using 18F-2-fluoro-2-deoxy-D-glucose and positron emission tomography: preliminary study of lung cancer.
Topics: Adult; Aged; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyglucose; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Middle Aged; Prognosis; Tomography, Emission-Computed | 1990 |